Mark Faries, MD
Surgery · New Haven, CTNPI 1659428969
Payments from drug & device makers
Across 255 payments — averaging $10,280 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$1.8M
- E.r. Squibb & Sons, L.L.C.$460K
- Modernatx, Inc.$330K
- Regeneron$12K
- Regeneron Healthcare Solutions, Inc.$4K
- Sanofi$4K
- plus $4K from 5 others
What the payments were for
- Consulting fees$60,83873%
- Speaking & faculty fees$10,25012%
- Travel & lodging$9,60411%
- Food & beverage$2,9454%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merck | 143 | $1,806,358 |
| E.r. Squibb & Sons, L.L.C. | 43 | $460,336 |
| Modernatx, Inc. | 44 | $329,865 |
| Regeneron | 11 | $12,203 |
| Regeneron Healthcare Solutions, Inc. | 4 | $4,311 |
| Sanofi | 2 | $3,905 |
| Novartis | 2 | $2,868 |
| Organon | 1 | $720 |
| Amgen | 2 | $517 |
| Iovance Biotherapeutics, Inc. | 2 | $274 |
| Array Biopharma Inc | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,621,372 in reported general payments places this provider in the 95th percentile of 289 surgery providers in Connecticut.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Imiquimod | 11 | $404 |
Paid to pharmacies, not to this prescriber.
Other surgery in New Haven
- John MortonNew Haven$970K
- Adrian MaungNew Haven$584K
- Andrew DuffyNew Haven$256K
- Anees ChagparNew Haven$121K
- Kelly OlinoNew Haven$93K
- Kurt RobertsNew Haven$53K
- Nita AhujaNew Haven$50K
- Sajid KhanNew Haven$48K
- Brian FleischerNew Haven$38K
- Brigid KilleleaNew Haven$31K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.